Curosurf

   
Google
 
Web NewDrugInformation.com

Curosurf


Drug - Curosurf
The trade name of the product as shown on the labeling.

Dosage - SUSPENSION; INTRATRACHEAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Poractant Alfa
Multiple ingredients are in alphabetical order.

Strength - 80MG/ML
The potency of the active ingredient(s), Poractant Alfa. May repeat for multiple part products.

Applicant - DEY
The firm name holding legal responsibility for Curosurf. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020744
The FDA assigned number to Curosurf. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Curosurf. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 18, 1999
The date Curosurf was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Curosurf. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Curosurf is in. Format is RX, OTC, DISCN.

Applicant Full Name - Dey Lp
The full name of the firm holding legal responsibility for the new application of Curosurf.

Curosurf